showed a trendp = 0.052
Effect of beta blocker therapy on additional secondary outcomes Patients with beta-blocker therapy showed a trend to lower NIHSS values at baseline (p = 0.052), while there was no difference in change in NIHSS, CRP or leukocyte count between both groups ( Table 4 ). mRS and Barthel-index were available for 203 patients with a median follow-up of 50 (IQR, 37–73) days.